HNGEHinge Health, Inc.
$102.86+81% 1Y
$102.86
$31.1752 weeks$102.86
Latest close: a new 52-week highOct 9, 2026what changed →
HNGE in its own filings
Nothing in HNGE's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
30
Events found in the filings · across 281 filings · the record starts in 2024
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 21, 2026
Most recent filing · Form 8-K
- Record starts
- Dec 13, 2024
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 3, 2026
- SEC comment-letter activity12 occurrences
- 2025-05-19
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 21, 2026On August 18, 2026, Hinge Health, Inc. (the “Company”) entered into an office lease agreement (the “Lease”) with 50 Beale Street LLC, a Delaware limited liability company (the “Landlord”), for approximately 119,278 rentable square feet located at 300 Mission Street, San Francisco, California (the “Premises”)Material agreement entered · Form 8-K
- Aug 4, 2026The Company's Board of Directors (the “Board”) previously approved a share repurchase program with authorization to purchase up to $250 million of its Class A common stock.Earnings release · Form 8-K
- Jun 9, 2026Hinge Health hosts its first Investor Day and raises guidance.Regulation FD disclosure · press release
- May 5, 2026Hinge Health reports record first quarter 2026 financial results.Earnings release · press release
- Mar 17, 2026Appointment of Tyler Sloat as Class I Director On March 16, 2026, the Board of Directors (the “Board”) of Hinge Health, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Tyler Sloat to serve as a member of the Board, effective immediately.Director or officer change · Form 8-K
- Feb 10, 2026Hinge Health reports fourth quarter and full year 2025 financial results.Earnings release · press release
- Nov 12, 2025On November 10, 2025, the Company’s Board of Directors approved a share repurchase program with authorization to purchase up to $250.0 million of its outstanding Class A Common Stock.Regulation FD disclosure · Form 8-K
- Nov 4, 2025Hinge Health reports third quarter 2025 financial results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Health Information Services
The closest names by size in the same industry